Published in Hospital Business Week, September 25th, 2005
"We have realized a number of important achievements in the first half of 2005 that will contribute significantly to the long-term value of the company," said Brent Norton, president and CEO. "We have started the 25,000-participant PREPARE (PREVU Predicts Atherosclerosis Risk and Events) clinical trial in the life insurance testing industry for PREVU LT (Lab Test) Skin Sterol Test, the lab-processed format of the technology - a study that includes LabOne...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.